Mirum Pharmaceuticals Community
NasdaqGM:MIRM Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 17 Fair Values set on narratives written by author
Community Investing Ideas
AN
Consensus Narrative from 10 Analysts
FDA And Japanese Approvals Will Open New Markets
Key Takeaways Strong revenue growth and recent regulatory approvals are set to expand market reach and positively impact future revenues. Advancing clinical pipeline and new product formulations could significantly boost future earnings by capturing greater market share.
View narrativeUS$68.60
FV
23.9% undervalued intrinsic discount20.27%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
7 days ago author updated this narrative